You do not have permission to edit this page, for the following reasons:

This IP address has been blocked from editing Wikipedia.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

The IP address or range 52.91.0.0/16 has been blocked (disabled) by ‪JJMC89‬ for the following reason(s):

The IP address that you are currently using has been blocked because it is believed to be a web host provider or colocation provider. To prevent abuse, web hosts and colocation providers may be blocked from editing Wikipedia.
You will not be able to edit Wikipedia using a web host or colocation provider because it hides your IP address, much like a proxy or VPN.
We recommend that you attempt to use another connection to edit. For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in.
If you do not have any other way to edit Wikipedia, you will need to request an IP block exemption.

How to appeal if you are confident that your connection does not use a colocation provider's IP address:
If you are confident that you are not using a web host, you may appeal this block by adding the following text on your talk page: ((unblock|reason=Caught by a colocation web host block but this host or IP is not a web host. My IP address is _______. Place any further information here. ~~~~)). You must fill in the blank with your IP address for this block to be investigated. Your IP address can be determined here. Alternatively, if you wish to keep your IP address private you can use the unblock ticket request system. There are several reasons you might be editing using the IP address of a web host or colocation provider (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host or colocation provider.

Administrators: The IP block exemption user right should only be applied to allow users to edit using web host in exceptional circumstances, and requests should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a CheckUser needs to take a look at the account. This can be requested most easily at SPI Quick Checkuser Requests. Unblocking an IP or IP range with this template is highly discouraged without at least contacting the blocking administrator.

This block will expire on 05:26, 2 September 2024.

Even when blocked, you will usually still be able to edit your user talk page, as well as email administrators and other editors.

For information on how to proceed, please read the FAQ for blocked users and the guideline on block appeals. The guide to appealing blocks may also be helpful.

Other useful links: Blocking policy · Help:I have been blocked
Your IP address is in a range that has been blocked on all Wikimedia Foundation wikis. The block was made by ‪Jon Kolbert‬. The reason given is Open proxy/Webhost: See the help page if you are affected .
- Start of block: 04:57, 27 November 2021
- Expiry of block: 04:57, 27 November 2024
Your current IP address is 52.91.194.66. The blocked range is 52.91.0.0/16. Please include all above details in any queries you make. If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy. Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.

You can view and copy the source of this page:

((Use dmy dates|date=April 2022))((Use New Zealand English|date=February 2024))

((More citations needed|date=December 2015))
((Infobox company
|name             = Pacific Edge Limited
|type             = [[Public company|Public]]
|traded_as        = ((nzx|PEB))
|foundation       = 2001
|location_city    = [[Dunedin]], New Zealand and [[Hershey, Pennsylvania|Hershey, USA]]
|location         =   <!--modifies "Headquarters" entry-->
|key_people       = David Darling<ref>((cite web|url=https://finance.yahoo.com/q/pr?s=peb.nz|title=PEB.NZ Profile - Pacific Edge Limited Ordinary S Stock - Yahoo! Finance|publisher=[[Yahoo! Finance]]|access-date=31 December 2015))</ref><ref>((cite web|url=http://www.nzherald.co.nz/pacific-edge-biotechnology-ltd/news/article.cfm?o_id=149&objectid=11551645|title=Pacific Edge first-half loss widens|work=[[The New Zealand Herald]]|access-date=31 December 2015))</ref> (Group CEO) and Jackie Walker (CEO of Pacific Edge Diagnostics USA)
|area_served      = New Zealand, Australia, Spain, United States of America
|industry         = [[Cancer#Diagnosis|Cancer diagnostics]]
|products         = CxBladder Suite of bladder cancer diagnostics tools
|services         = [[Urology]]
|revenue          = $4m as at November 2015
|num_employees    = Approx 50 globally
|parent           = 
|divisions        =
|caption           = 
|homepage         = ((URL|pacificedgedx.com))
|dissolved        = 
|footnotes        = 
))
'''Pacific Edge Limited,''' based in [[New Zealand]], focuses on [[cancer]] diagnostics with a suite of bladder cancer diagnostic tools using genetic [[Biomarker|biomarkers.]] The company operates with a head office in [[Dunedin]], New Zealand, and also has an office in [[Hershey, Pennsylvania|Hershey]], USA. It is listed on the New Zealand [[NZX]] main board stock exchange and is included in the [[NZX 50 Index]].<ref>((cite web |title=Pacific Edge Limited |url=https://www.nzx.com/companies/PEB |access-date=31 December 2015 |publisher=))</ref>

==History==
Pacific Edge, founded in August 2001,<ref>((cite web |title=NZX Main Board - PEB Analysis |url=https://www.nzx.com/markets/NZSX/securities/PEB/analysis |access-date=31 December 2015 |publisher=[[NZX]] |quote=Pacific Edge Limited (PEB) was formed in August 2001 following acquisition of intellectual property from the [[University of Otago]].))</ref> utilizes genetic [[biomarker]]s in [[urine]] for [[cancer detection]]. Their approach is positioned as cost-effective compared to other diagnostic methods.<ref>((Cite news |date=2013-10-22 |title=Pacific Edge shares soar to new high |url=http://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=11144239 |access-date=2015-12-31 |newspaper=New Zealand Herald |language=en-NZ |issn=1170-0777))</ref> The company offers diagnostic services in [[New Zealand]] and the [[United States]] and has partnerships in [[Europe]] and [[Australia]].

Listed on the New Zealand NZX index, Pacific Edge has undertaken capital raising initiatives, with rounds in 2013 and 2015 aimed at advancing the [[commercialization]] of their diagnostic tests in the United States.<ref>((cite web |title=Pacific Edge seeks $35.3M to fund US growth |url=http://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=11460387 |access-date=31 December 2015 |work=The New Zealand Herald))</ref> In June 2020, Pacific Edge secured a commercial relationship with [[Kaiser Permanente]], one of the largest [[health insurance provider]]s in the U.S., for its bladder cancer tests.<ref>((Cite web|title=Kaiser Permanente Approves Commercial Use of Cxbladder - NZX, New Zealand's Exchange|url=https://www.nzx.com/announcements/354817|access-date=2020-06-25|website=www.nzx.com))</ref>

==Products==
Pacific Edge offers a series of bladder cancer diagnostic tests known as CxBladder. These tests include specialist subtype products designed for the detection of [[cancerous cell]]s and to aid [[clinician]]s and [[oncologists]] in [[triage]].<ref>((cite web |date=29 December 2015 |title=Suite of cancer products grows |url=http://www.odt.co.nz/news/business/368229/suite-cancer-products-grows |access-date=31 December 2015 |publisher=[[Otago Daily Times]]))</ref> The tests are based on [[Non-invasive procedure|non-invasive]] [[urine samples]], utilizing [[RNA]] and protein assays. CxBladder is noted for its sensitivity and potential for earlier detection of [[bladder cancer]], compared to other [[diagnostic method]]s such as [[cytology]].<ref>((cite web |author=Alan Wood |date=27 May 2015 |title=Pacific Edge's FY loss widens to $10.58m, plans to raise $35.3m |url=http://www.stuff.co.nz/business/68921200/pacific-edges-fy-loss-widens-to-1058m-plans-to-raise-353m |access-date=31 December 2015 |work=[[Stuff.co.nz]]))</ref><ref>((cite web |author=Janis C. Kelly |date=26 October 2015 |title=Urinary Biomarkers Not Useful for Bladder Cancer Diagnosis |url=http://www.medscape.com/viewarticle/853218 |access-date=31 December 2015 |publisher=[[Medscape]]))</ref><ref>((cite web |author=MARTA STEEMAN |date=9 June 2015 |title=Singapore hospital to trial Pacific Edge's main bladder cancer detection product |url=http://www.stuff.co.nz/business/69243267/singapore-hospital-to-trial-pacific-edges-main-bladder-cancer-detection-product |access-date=31 December 2015 |work=[[Stuff.co.nz]]))</ref><ref>((cite web |date=11 July 2014 |title=Warning over bladder cancer test |url=http://www.stuff.co.nz/national/health/10255639/Warning-over-bladder-cancer-test |access-date=31 December 2015 |work=[[Stuff.co.nz]]))</ref><ref>((cite web |date=27 November 2015 |title=Pacific Edge sales up; still no profit |url=http://www.odt.co.nz/news/business/364853/pacific-edge-sales-still-no-profit |access-date=31 December 2015 |publisher=[[Otago Daily Times]]))</ref><ref>((cite web |title=Pacific Edge gets US approval for Dunedin laboratory |url=http://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=11495605 |access-date=31 December 2015 |work=[[The New Zealand Herald]]))</ref>

==Awards==
Pacific Edge has won a number of awards, including:

*[http://www.innovators.org.nz/winners-a-finalists/winners-2013 The NZ Innovators Award 2013]
*[https://www.baldwins.com/news/pacific-edge-has-the-edge-at-nzbio-awards NZBIO Biotech company of the year award 2014]
* [http://www.pacificedgedx.com/news-and-events/news/2016/pacific-edge-wins-mtanz-innovation-award-for-cxbladder-technology/ Medical Technology Association of New Zealand Innovation Award 2016]

==References==
((Reflist))

==External links==
* [http://pacificedgedx.com Official site]

((authority control))

((NZX 50 companies))

[[Category:Urology organizations]]
[[Category:New Zealand brands]]
[[Category:Companies listed on the New Zealand Exchange]]
[[Category:Companies in the S&P/NZX 50 Index]]
[[Category:Companies based in Dunedin]]
[[Category:Companies established in 2001]]
[[Category:Medical technology companies of New Zealand]]
[[Category:New Zealand companies established in 2001]]

Pages transcluded onto the current version of this page (help):

Pacific Edge Limited (edit)
Template:Ambox (view source) (template editor protected)
Template:Authority control (view source) (template editor protected)
Template:Cite news (view source) (protected)
Template:Cite web (view source) (protected)
Template:Comma separated entries (view source) (template editor protected)
Template:DMCA (view source) (template editor protected)
Template:Dated maintenance category (view source) (template editor protected)
Template:Dated maintenance category (articles) (view source) (template editor protected)
Template:FULLROOTPAGENAME (view source) (template editor protected)
Template:Find sources mainspace (view source) (template editor protected)
Template:Hlist/styles.css (view source) (protected)
Template:Infobox (view source) (template editor protected)
Template:Infobox company (view source) (template editor protected)
Template:Longitem (view source) (template editor protected)
Template:Main other (view source) (protected)
Template:More citations needed (view source) (template editor protected)
Template:NZX 50 companies (edit)
Template:Navbox (view source) (template editor protected)
Template:New Zealand Exchange (edit)
Template:Ns has subpages (view source) (protected)
Template:Nzx (edit)
Template:Reflist (view source) (protected)
Template:Reflist/styles.css (view source) (protected)
Template:Template other (view source) (protected)
Template:URL (view source) (template editor protected)
Template:Use New Zealand English (view source) (template editor protected)
Template:Use dmy dates (view source) (template editor protected)
Template:Wikidata (view source) (template editor protected)
Module:Arguments (view source) (protected)
Module:Authority control (view source) (template editor protected)
Module:Authority control/config (view source) (template editor protected)
Module:Category handler (view source) (protected)
Module:Category handler/blacklist (view source) (protected)
Module:Category handler/config (view source) (protected)
Module:Category handler/data (view source) (protected)
Module:Category handler/shared (view source) (protected)
Module:Check for clobbered parameters (view source) (template editor protected)
Module:Check for unknown parameters (view source) (protected)
Module:Citation/CS1 (view source) (protected)
Module:Citation/CS1/COinS (view source) (protected)
Module:Citation/CS1/Configuration (view source) (protected)
Module:Citation/CS1/Date validation (view source) (protected)
Module:Citation/CS1/Identifiers (view source) (protected)
Module:Citation/CS1/Utilities (view source) (protected)
Module:Citation/CS1/Whitelist (view source) (protected)
Module:Citation/CS1/styles.css (view source) (protected)
Module:Find sources (view source) (template editor protected)
Module:Find sources/config (view source) (template editor protected)
Module:Find sources/links (view source) (template editor protected)
Module:Find sources/templates/Find sources mainspace (view source) (template editor protected)
Module:Infobox (view source) (template editor protected)
Module:Infobox/styles.css (view source) (template editor protected)
Module:InfoboxImage (view source) (template editor protected)
Module:Message box (view source) (protected)
Module:Message box/ambox.css (view source) (protected)
Module:Message box/configuration (view source) (protected)
Module:Namespace detect/config (view source) (protected)
Module:Namespace detect/data (view source) (protected)
Module:Navbar (view source) (protected)
Module:Navbar/configuration (view source) (protected)
Module:Navbar/styles.css (view source) (protected)
Module:Navbox (view source) (template editor protected)
Module:Navbox/configuration (view source) (template editor protected)
Module:Navbox/styles.css (view source) (template editor protected)
Module:Ns has subpages (view source) (protected)
Module:Separated entries (view source) (protected)
Module:TableTools (view source) (protected)
Module:URL (view source) (template editor protected)
Module:Unsubst (view source) (protected)
Module:Wd (view source) (template editor protected)
Module:Wd/i18n (view source) (template editor protected)
Module:WikidataIB (view source) (template editor protected)
Module:WikidataIB/nolinks (view source) (template editor protected)
Module:WikidataIB/titleformats (view source) (template editor protected)
Module:Yesno (view source) (protected)

Return to Pacific Edge Limited.

Retrieved from "https://en.wikipedia.org/wiki/Pacific_Edge_Limited"